Primary breast tumors are typed according to hormonal receptor status (estrogen receptor (ER), progesterone receptor (PR), and Erb-B2 receptor tyrosine kinase 2 (ERBB2 or HER2) amplification); and in some cases, the presence of specific mutations or changes in gene copy number also help to determine treatment. Here, PGR is linked to breast neoplasm.